MicroRNA-363-3p, negatively regulated by long non-coding RNA small nucleolar RNA host gene 5, inhibits tumor progression by targeting Aurora kinase A in colorectal cancer
MicroRNA-363-3p (miR-363-3p), reportedly, exhibits a tumor-suppressive role in human malignancies. Herein, our research was designed to further explain the functions and molecular mechanisms of miR-363-3p in the progression of colorectal cancer (CRC). With in vitro models, this study found that miR-363-3p was markedly under-expressed in CRC tissues and cells, and its overexpression suppressed the viability, migration, and invasion of CRC cells, and promoted cell apoptosis, whereas inhibiting miR-363-3p expression exhibited an opposite role. Additionally, aurora kinase A (AURKA), capable of counteracting the impacts of miR-363-3p on malignant biological behaviors of CRC cells, was identified as a direct target of miR-363-3p. Besides, miR-363-3p was sponged by long non-coding RNA small nucleolar RNA host gene 5 (SNHG5), which suppressed miR-363-3p expression. This research shows that SNHG5/miR-363-3p/AURKA axis partakes in CRC progression.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Bioengineered - 13(2022), 3 vom: 15. März, Seite 5357-5372 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Guo, Qiuyun [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 11.04.2022 Date Revised 11.07.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1080/21655979.2021.2018972 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336987072 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336987072 | ||
003 | DE-627 | ||
005 | 20231225233406.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/21655979.2021.2018972 |2 doi | |
028 | 5 | 2 | |a pubmed24n1123.xml |
035 | |a (DE-627)NLM336987072 | ||
035 | |a (NLM)35166647 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Guo, Qiuyun |e verfasserin |4 aut | |
245 | 1 | 0 | |a MicroRNA-363-3p, negatively regulated by long non-coding RNA small nucleolar RNA host gene 5, inhibits tumor progression by targeting Aurora kinase A in colorectal cancer |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.04.2022 | ||
500 | |a Date Revised 11.07.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a MicroRNA-363-3p (miR-363-3p), reportedly, exhibits a tumor-suppressive role in human malignancies. Herein, our research was designed to further explain the functions and molecular mechanisms of miR-363-3p in the progression of colorectal cancer (CRC). With in vitro models, this study found that miR-363-3p was markedly under-expressed in CRC tissues and cells, and its overexpression suppressed the viability, migration, and invasion of CRC cells, and promoted cell apoptosis, whereas inhibiting miR-363-3p expression exhibited an opposite role. Additionally, aurora kinase A (AURKA), capable of counteracting the impacts of miR-363-3p on malignant biological behaviors of CRC cells, was identified as a direct target of miR-363-3p. Besides, miR-363-3p was sponged by long non-coding RNA small nucleolar RNA host gene 5 (SNHG5), which suppressed miR-363-3p expression. This research shows that SNHG5/miR-363-3p/AURKA axis partakes in CRC progression | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a AURKA | |
650 | 4 | |a Colorectal cancer | |
650 | 4 | |a SNHG5 | |
650 | 4 | |a invasion and apoptosis | |
650 | 4 | |a miR-363-3p | |
650 | 4 | |a proliferation | |
650 | 7 | |a MIRN363 microRNA, human |2 NLM | |
650 | 7 | |a MicroRNAs |2 NLM | |
650 | 7 | |a RNA, Long Noncoding |2 NLM | |
650 | 7 | |a RNA, Small Nucleolar |2 NLM | |
650 | 7 | |a long non-coding RNA SNHG5, human |2 NLM | |
650 | 7 | |a Aurora Kinase A |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
700 | 1 | |a Dong, Lujia |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Chenxiao |e verfasserin |4 aut | |
700 | 1 | |a Liu, Dechun |e verfasserin |4 aut | |
700 | 1 | |a Peng, Ping |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bioengineered |d 2012 |g 13(2022), 3 vom: 15. März, Seite 5357-5372 |w (DE-627)NLM218688679 |x 2165-5987 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2022 |g number:3 |g day:15 |g month:03 |g pages:5357-5372 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/21655979.2021.2018972 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2022 |e 3 |b 15 |c 03 |h 5357-5372 |